50+ Years of Improving Health
MSH enters into a 15-year relationship with the Philippines to improve family planning and child health services, develop a national health information system, and enroll low-income families in health insurance.
As a strategy for promoting improved pharmaceutical use, MSH establishes the International Network for Rational Use of Drugs (INRUD) to improve medicines management.
In Rwanda, MSH launches performance-based financing programs for health services, dramatically increasing HIV testing, assisted births, and contraceptive use.
MSH publishes Managers Who Lead: A Handbook for Improving Health Services, its seminal publication providing practical strategies and tools for health care managers.
MSH supports Malawi to implement an ambitious and pioneering “test-and-treat” HIV strategy for pregnant and breastfeeding women, known as Option B+.
MSH publishes the third edition of MDS-3: Managing Access to Medicines and Health Technologies, the world’s leading reference on managing essential medicines in developing countries.
On March 23, 2014, WHO reports cases of Ebola Virus Disease in the forested rural region of southeastern Guinea. The identification of these early cases marks the beginning of the West Africa Ebola epidemic, the largest in history.
MSH assists local officials, community health workers, and public and private health care providers to respond to Ebola outbreaks while continuing to rebuild health systems and supply chains in affected countries, including Liberia and Democratic Republic of the Congo.
The Global Health Security Agenda is launched to prevent, detect, and respond to emerging infectious disease threats, whether natural, accidental, or intentional.
The MDGs are updated to the 17 Sustainable Development Goals (SDGs), with emphasis on reaching the most vulnerable first. SDG 3 calls for ensuring healthy lives and promoting well-being for all, including achieving universal health coverage (UHC).
To respond to the high cost and low quality of medicines in Kenya, MSH launches MedSource, a private group purchasing organization. MedSource now facilitates the procurement of more than 1,000 health care products.
MSH, Harvard University, Georgetown University, and the Stone Foundation assemble leading voices in global health security to discuss the state of the world’s readiness to fight the next epidemic.
The Bureau for Global Health ranks the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program as 1 of the top 5 most useful USAID projects—out of a field of more than 150 projects.
MSH continues a 40-year tradition of global excellence and innovation in pharmaceutical systems as it launches a new five-year global project, the USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program.
Through the Accessible Continuum of Care and Essential Services (ACCESS) Activity, MSH continues to support the Government of Madagascar to accelerate health improvements for 16 million people.
MSH is selected by the Joint Learning Network for Universal Health Coverage (JLN) Steering Group to serve as Network Manager under an agreement with the Bill & Melinda Gates Foundation.
MSH begins hosting the Secretariat for the Civil Society Engagement Mechanism (CSEM) for UHC2030. CSEM endeavors to elevate civil society’s influence to ensure that UHC policies and programs are inclusive and equitable.